Please login to the form below

Not currently logged in
Email:
Password:

clinical trials

This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.

AZ taps Ionis for another drug, this time in NASH

AZ taps Ionis for another drug, this time in NASH

The two companies are also collaborating on AZD4785 - a candidate that targets the KRAS oncogene and started clinical trials in solid tumours last year - and STAT3-targeting AZD9150, which is being ... We look forward to AZ moving this programme swiftly

Latest news

More from news
Approximately 160 fully matching, plus 1,033 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    testing into clinical trials. ... Funding initiatives such as CARB-X, ENABLE and GARD-P have pledged around $600m for pre-clinical to clinical translation of new treatments and diagnostics.

  • Beyond caring: learning from the unsung advocates in cancer care

    Often, advocates lack the support to easily overcome these inequalities. Many describe how clinicians don’t automatically include them in important conversations about diagnosis or clinical trials, how they constantly have

  • A critical juncture for clinical data management A critical juncture for clinical data management

    sources captured during clinical trials. ... Life science companies want to collect more data from more sources, in order to make faster, more accurate decisions during clinical trials.

  • A new era of smart pharma A new era of smart pharma

    Clearly protocol endpoints and regulatory expectations must be addressed in any pre-authorisation trials. ... clinical trials and enhance public health, the insights delivered by AI will only be as good as the data it analyses.

  • Digital health Digital health

    Medicine works best when it is a collaboration. If something is going to be clinically significant, it needs to be built-in collaboration with practicing clinical expertise, clinical academia, patient advocacy ... The solution, which combines tools based

More from intelligence
Approximately 8 fully matching, plus 125 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby said: “My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market.

  • Life Healthcare appoints two new starters Life Healthcare appoints two new starters

    Joining Alisha is Caitlin McMaster (pictured right), who takes up an account executive role at Life Healthcare, working alongside the clinical trials team.

  • Topas Therapeutics appoints chief development officer and chief medical officer Topas Therapeutics appoints chief development officer and chief medical officer

    Timm Jessen, chief executive officer, Topas, said: “Rupert has a long and successful track record of bringing drugs and biologics through clinical development and regulatory approval. ... At Topas, Dr. Sandbrink will guide projects into the clinic,

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    Meanwhile, Valles-Sukkar arrives at TiGenix from Alexion Pharmaceuticals, where she was responsible for all aspects of clinical trial development. ... Annette has proven ability to manage large-scale late-stage clinical trials.”.

  • Teckro appoints Dana Poff as COO Teckro appoints Dana Poff as COO

    She said: “I am excited to be part of an organisation focused on simplifying the approach to conducting clinical trials and reducing the burden on sites and patients. ... Gary Hughes, co-founder and CEO at Teckro, said: “Dana’s knowledge and

More from appointments
Approximately 0 fully matching, plus 60 partially matching documents found.

Latest from PMHub

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    so.Unfortunately, the complexity of the disease has meant that many recent AD trials have been unsuccessful. ... molecules for application in new trials and investigations.

  • Alzheimer's: the numbers we cannot forget

    During this period, 413 trials were performed using 95 compounds with  8 unique modes of action (MOAs). ... the cost of AD trials and the amount of investment that has been made with little to no return is shocking.

  • Investigator meetings deconstructed

    Clinical trials and investigator meetings are intrinsically linked. The arduous clinical trial process is designed to train site personnel and ensure they are versed on the protocol, regulatory issues, enrollment procedures ... Investigator meetings can

  • How can pharma help the NHS drive much-needed change in mental health services?

    How can pharma help? There is a big role for pharma in funding research and conducting clinical trials to further explore the side effects of drugs which are used for conditions, ... Conclusion. To help improve treatments and outcomes in mental health,

  • Engaging patients in their clinical trial journey

    Consequently, multimedia content in your patients’ own languages is a must for successful clinical trial communication. ... The same trends for engagement can be followed by those in the clinical trials industry when communicating with patients.

More from PMHub
Approximately 18 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics